Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Spectral Medical Inc
T.EDT
Alternate Symbol(s):
EDTXF
Healthcare
Biotechnology
Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the...
bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:EDT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(57)
•••
daviking
X
View Profile
View Bullboard History
Comment by
daviking
on Nov 20, 2024 8:47pm
RE:For those that want to learn the real reason for IV shortage
Well, big corporations are definetly looking after themselves at the expense of the consumer/average Joe!
(307)
•••
BlueJays9293
X
View Profile
View Bullboard History
Post by
BlueJays9293
on Nov 20, 2024 7:33pm
For those that want to learn the real reason for IV shortage
(402)
•••
Revten
X
View Profile
View Bullboard History
Post by
Revten
on Nov 20, 2024 2:17pm
TODAY’S MID-DAY ACTION
House Positions for C:EDT from 20241120 to 20241120 House Bought $Val Ave Sold $Val Ave Net $Net 7
...more
(32)
•••
Geery
X
View Profile
View Bullboard History
Comment by
Geery
on Nov 20, 2024 1:55pm
RE:RE:RE:RE:RE:large amount on bid side
Level 2 showing 4 orders, 1,025,500 shares at $0.50 on the Bid.
(95)
•••
oilandgasman
X
View Profile
View Bullboard History
Comment by
oilandgasman
on Nov 20, 2024 12:57pm
RE:RE:RE:RE:RE:large amount on bid side
My guess is another round of financing is on the way.
(784)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Nov 20, 2024 11:53am
RE:RE:RE:RE:large amount on bid side
Don't even need Level 2 now. Looks like it's happening at .50 or .51. I hope no one is offended that I am taking advantage of the opportunity to reload my trading position to the
...more
(402)
•••
Revten
X
View Profile
View Bullboard History
Post by
Revten
on Nov 19, 2024 9:45pm
TODAY’S NUMBERS
House Positions for C:EDT from 20241119 to 20241119 House Bought $Val Ave Sold $Val Ave Net $Net 1
...more
(402)
•••
Revten
X
View Profile
View Bullboard History
Post by
Revten
on Nov 18, 2024 8:40pm
TODAY’S NUMBERS
House Positions for C:EDT from 20241118 to 20241118 House Bought $Val Ave Sold $Val Ave Net $Net 2
...more
(307)
•••
BlueJays9293
X
View Profile
View Bullboard History
Post by
BlueJays9293
on Nov 18, 2024 7:39pm
Turns out,
also removing Albumin & Platelets, isn't such a good idea. Albumin and platelet loss during the application of CytoSorb® in critically ill patients: a post-hoc analysis of the
...more
(57)
•••
daviking
X
View Profile
View Bullboard History
Comment by
daviking
on Nov 17, 2024 12:46pm
RE:RE:RE:RE:RE:RE:BioTuesdays Feature Article on Spectral
On BlueJays8293 video link, at about 19 minute mark on SMART Congress video.
(307)
•••
BlueJays9293
X
View Profile
View Bullboard History
Comment by
BlueJays9293
on Nov 16, 2024 6:05pm
RE:RE:RE:RE:RE:BioTuesdays Feature Article on Spectral
(307)
•••
BlueJays9293
X
View Profile
View Bullboard History
Comment by
BlueJays9293
on Nov 16, 2024 6:04pm
RE:RE:RE:RE:RE:BioTuesdays Feature Article on Spectral
Estors page on Hemofeel. https://www.estor.it/en/therapareas/hemofeel/
(307)
•••
BlueJays9293
X
View Profile
View Bullboard History
Comment by
BlueJays9293
on Nov 16, 2024 6:02pm
RE:RE:RE:RE:BioTuesdays Feature Article on Spectral
There is another Toray product called Hemofeel that I think Vantive will want in their blood purification portfolio. Hemofeel is a cartridge that is similar to Oxiris but it filters cytokines in
...more
(784)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Nov 16, 2024 3:08pm
RE:RE:RE:RE:BioTuesdays Feature Article on Spectral
Typically such pre-existing DA's have expiry dates, or performance requirements (ie minimums). Often they are not exclusive. Even so, it could take years for someone
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario